Journal
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
Volume 189, Issue 6, Pages 1666-1669Publisher
MOSBY-ELSEVIER
DOI: 10.1016/S0002-9378(03)00907-4
Keywords
serine/threonine phosphatase; endometrial cancer; protein phosphatase 2A; immunoblotting; antiproliferative action
Categories
Ask authors/readers for more resources
OBJECTIVE: Reversible serine/threonine protein phosphorylation catalyzed by kinases and phosphatases plays a crucial role in cellular growth and differentiation. We attempted to determine the subcellular location of serine/threonine phosphatase (protein phosphatase type 2A [PP2A]) in endometrial cancer. STUDY DESIGN: Endometrial cancers surgically removed were examined. PP2A activity was assessed by measuring the dephosphorylation of phosphopeptide highly selective for the PP2A in cytosol and membranes fractionated on a continuous sucrose density gradient. Its protein level was detected by immunoblotting with a specific antibody. RESULTS: There were three peaks of PP2A enzyme activity and immunoreactivity corresponding by marker enzyme analysis to the cytoplasm, plasma membrane, and endoplasmic reticulum fractions. An enzyme kinetic analysis showed the different activity in cytosol and plasma membrane; Km values of 98 +/- 12 mumol/L for cytosol and 32 +/- 6.2 mumol/L for plasma membrane (P<.01), respectively. The membrane phosphatase was sensitive to inhibition by okadaic acid and sodium fluoride, characteristics suggestive of PP2A activity. CONCLUSION: PP2A activity in the plasma membrane of endometrial cancers might be distinct from that present in the cytosol. The plasma membrane PP2A may be responsible for a rapid and initial decrease in intracellular level of phosphoserine and phosphothreonine, interfering with serine/threonine protein phosphorylation-mediated growth of endometrial cancer. (Am J Obstet Gynecol 2003;189:1666-9.)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available